Medicinova (MNOV) Other Non Operating Income (2010 - 2026)
Medicinova (MNOV) posted quarterly Other Non Operating Income of $27236.0 for Q4 2025, down 94.11% year-over-year from $462050.0 in Q4 2024, and up 366.37% quarter-over-quarter from -$10225.0 in Q3 2025.
Medicinova (MNOV) Other Non Operating Income (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Other Non Operating Income for 16 consecutive years, with $27236.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non Operating Income fell 94.11% year-over-year to $27236.0; the TTM figure through Dec 2025 stood at $20242.0 (down 95.38% YoY), while the FY2025 annual figure was $20242.0, down 95.38% from the prior year.
- Other Non Operating Income rose to $27236.0 in Q4 2025 per MNOV's latest filing, from -$10225.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $462050.0 in Q4 2024 and bottomed at -$463307.0 in Q1 2023.
- Historically, Other Non Operating Income has averaged -$17567.4 across 5 years, with a median of -$13562.5 in 2021.
- Annual changes were most pronounced in 2023 — Other Non Operating Income sank 3270.98% — and 2024, when it jumped 21111.82%.
- Medicinova's Other Non Operating Income stood at -$14213.0 in 2021, then tumbled by 1270.09% to -$194731.0 in 2022, then jumped by 98.87% to -$2199.0 in 2023, then surged by 21111.82% to $462050.0 in 2024, then tumbled by 94.11% to $27236.0 in 2025.
- Business Quant data shows MNOV's Other Non Operating Income at $27236.0 in Q4 2025, -$10225.0 in Q3 2025, and $952.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,881.00 |
| Dec 31, 2025 | 27,236.00 |
| Sep 30, 2025 | -10,225.00 |
| Jun 30, 2025 | 952.00 |
| Mar 31, 2025 | 2,279.00 |
| Dec 31, 2024 | 462,050.00 |
| Sep 30, 2024 | 9,102.00 |
| Jun 30, 2024 | -17,055.00 |
| Mar 31, 2024 | -16,035.00 |
| Dec 31, 2023 | -2,199.00 |
| Sep 30, 2023 | -14,153.00 |
| Jun 30, 2023 | -23,210.00 |
| Mar 31, 2023 | -463,307.00 |
| Dec 31, 2022 | -194,731.00 |
| Sep 30, 2022 | -8,472.00 |
| Jun 30, 2022 | -30,338.00 |
| Mar 31, 2022 | -13,744.00 |
| Dec 31, 2021 | -14,213.00 |
| Sep 30, 2021 | -13,381.00 |
| Jun 30, 2021 | -8,966.00 |